Pieris' Reverse Merger Round

Pieris raised a round of funding on December 18, 2014. Investors include Pieris.

Pieris is an independent, clinical-staged biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that are safer and more effective than conventional approa…

Articles about Pieris' Reverse Merger Round: